hepatocellular cancer

Showing 1 - 25 of 79

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatocellular Carcinoma Non-resectable Trial in Seoul (Atezolizumab plus

Recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Atezolizumab plus bevacizumab, combined EBRT to vascular invasion
  • Atezolizumab plus bevacizumab
  • Seoul, Korea, Republic of
    Asan Medical Center
Aug 7, 2023

Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Pancreatic Cancer Trial run by the NCI (nivolumab, tadalafil, oral

Completed
  • Hepatocellular Carcinoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Pancreatic Cancer, Hepatocellular Cancer, Biliary Tract Cancer Trial in Edmonton (Durvalumab, Gemcitabine, Nab paclitaxel)

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Durvalumab
  • +5 more
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Feb 1, 2023

Resectable Hepatocellular Carcinoma, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Boston (Durvalumab, Tremelimumab,

Not yet recruiting
  • Resectable Hepatocellular Carcinoma
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 18, 2023

Carcinoma, Hepatocellular, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Seoul (Microwave ablation)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • +3 more
  • Microwave ablation
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jan 23, 2023

Hepatocellular Cancer, Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial run by the NCI (durvalumab,

Recruiting
  • Hepatocellular Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Hepatocellular Carcinoma Trial run by the NCI (Cyclophosphamide,

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Advanced Solid Tumor, Castration-Resistant Prostatic Cancer, Malignant Melanoma Trial in United States (MGC018, lorigerlimab)

Recruiting
  • Advanced Solid Tumor
  • +6 more
  • vobramitamab duocarmazine
  • lorigerlimab
  • Los Angeles, California
  • +7 more
Jan 10, 2023

Hepatocellular Cancer, Microwave Ablation, Microwave Thermosphere Ablation Trial (True circular microwave needle)

Recruiting
  • Hepatocellular Cancer
  • +3 more
  • True circular microwave needle
  • Tianjin, Tianjin, China
    Tianjin Third Central Hospital
Dec 11, 2022

Hepatocellular Cancer Trial in Phoenix, Chicago, Winston-Salem (device, drug, other)

Recruiting
  • Hepatocellular Cancer
  • TheraBionic Device
  • +2 more
  • Tampa, Florida
  • +6 more
Dec 12, 2022

Hepatocellular Cancer, Liver Cirrhoses, Diagnoses Disease Trial in Tianjin (Diagnostic Sonazoid-CEUS and EOB-MRI)

Recruiting
  • Hepatocellular Cancer
  • +2 more
  • Diagnostic Sonazoid-CEUS and EOB-MRI
  • Tianjin, Tianjin, China
    Tianjin Third Central Hospital
Dec 11, 2022

d To Treat People With Hepatocellular Carcinoma

Recruiting
  • Hepatocellular Cancer
  • Tokyo, Japan
    Takeda Selected Site
Dec 5, 2022

Carcinoma, Hepatocellular, Hepatic Carcinoma, Hepatocellular Cancer Trial in Hannover (Nivolumab, TACE)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • +2 more
  • Hannover, Germany
    Medizinische Hochschule Hannover, Klinik für Gastroenterologie,
Nov 21, 2022

Renal Cell Cancer, Melanoma, Non-Small-Cell Lung Cancer Trial in Duarte, Louisville, New York (PF-07263689, Sasanlimab)

Active, not recruiting
  • Renal Cell Cancer
  • +9 more
  • PF-07263689
  • Sasanlimab
  • Duarte, California
  • +5 more
Nov 8, 2022

Blood, Urine, and Bone Marrow

Recruiting
  • Non Small Cell Lung Cancer
  • +5 more
  • Test for circulating tumor cells, DNA alterations
  • Columbia, Missouri
    Harry S Truman Veterans Memorial Hospital
Oct 31, 2022

Vascular Invasion Signatures in cfDNA Support Re-staging of

Completed
  • Carcinoma, Hepatocellular
  • +2 more
  • Liver resection
  • Shanghai, Shanghai, China
    Eastern Hepatobiliary Surgery Hospital, Naval Medical University
Sep 15, 2022

Hepatocellular Cancer Trial in San Antonio (Sorafenib (SOR), Hydroxychloroquine (HCQ))

Recruiting
  • Hepatocellular Cancer
  • Sorafenib (SOR)
  • Hydroxychloroquine (HCQ)
  • San Antonio, Texas
    University of Texas Health Cancer Center
Sep 16, 2022

Hepatocellular Cancer, AFP Expressing Tumors Trial in Worldwide (Autologous genetically modified AFP?³³²T cells)

Active, not recruiting
  • Hepatocellular Cancer
  • AFP Expressing Tumors
  • Autologous genetically modified AFPᶜ³³²T cells
  • Phoenix, Arizona
  • +20 more
Aug 26, 2022

Hepatocellular Carcinoma, Hepatocellular Cancer, Colorectal Cancer Trial in Singapore (Neoantigen Dendritic Cell Vaccine,

Recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Singapore, Singapore
    National Cancer Center Singapore
Aug 17, 2022

Hepatocellular Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Germany (FoundationOne®CDx and FoundationOne®Liquid)

Recruiting
  • Hepatocellular Cancer
  • +5 more
  • FoundationOne®CDx and FoundationOne®Liquid
  • Frankfurt, Hessen, Germany
  • +29 more
Aug 12, 2022

The PLATON Network

Recruiting
  • Hepatocellular Cancer
  • +5 more
    • Frankfurt, Hessen, Germany
    • +30 more
    Aug 12, 2022

    Hepatocellular Carcinoma, Solid Tumor, Hepatocellular Carcinoma Non-resectable Trial in San Antonio (OTX-2002, Tyrosine kinase

    Not yet recruiting
    • Hepatocellular Carcinoma
    • +6 more
    • San Antonio, Texas
      Next Oncology
    Aug 9, 2022

    Hepatocellular Cancer Trial in Shanghai (Anlotinib;Toripalimab)

    Recruiting
    • Hepatocellular Cancer
    • Shanghai, Shanghai, China
      Eastern hepatobilliary surgery hospital
    Jul 7, 2022

    Esophageal Cancer, Gastric Cancer, Hepatocellular Cancer Trial (Q702, Pembrolizumab)

    Not yet recruiting
    • Esophageal Cancer
    • +3 more
    • (no location specified)
    Jun 27, 2022